Myelodysplastic Syndrome After Anti-CD19 Chimeric Antigen Receptor T-cell Therapy: A Case Series

The utility of CD19-targeted chimeric antigen receptor T-cell (CAR-T cell) therapy in the management of refractory/relapsed B-cell malignancies has increased tremendously in recent times. In addition to cytokine release syndrome (CRS), neurotoxicity, and infections, CAR-T cell patients develop cytop...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhaliwal, Armaan, Ravi, Soumiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550779/
https://www.ncbi.nlm.nih.gov/pubmed/37809221
http://dx.doi.org/10.7759/cureus.44677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10550779/
https://www.ncbi.nlm.nih.gov/pubmed/37809221
http://dx.doi.org/10.7759/cureus.44677

Ejemplares similares